How does tramadol affect blood pressure. What are the potential side effects of tramadol. Can tramadol interact with other medications. How long do the effects of tramadol last. What is the proper way to take tramadol.

Understanding Tramadol: A Synthetic Opioid for Pain Management

Tramadol is a synthetic opioid medication prescribed for moderate to severe pain relief. It works by blocking pain receptors in the central nervous system, similar to other opioids. Doctors often prescribe tramadol for post-surgical pain or chronic conditions like cancer and neuropathy.

What are the common brand names for tramadol?

• Ultram
• Ultracet
• Qdolo
• ConZip

Tramadol’s Impact on Blood Pressure: What You Need to Know

While tramadol is not primarily known for its effects on blood pressure, some studies have shown a correlation between the medication and blood pressure changes. These effects, however, are relatively rare.

What percentage of tramadol users experience blood pressure changes?

• 1-5% of users develop high blood pressure (hypertension)
• Less than 1% of users develop low blood pressure (hypotension)

It’s important to note that while tramadol itself may not directly interact with blood pressure medications, its interactions with other drugs can potentially affect blood pressure levels.

Potential Drug Interactions with Tramadol

Tramadol can interact with various medications, potentially leading to adverse effects, including blood pressure fluctuations. Understanding these interactions is crucial for safe usage.

What types of medications can interact with tramadol?

1. Antidepressants
2. Headache medications
3. Hypnotics
4. Benzodiazepines
5. Antipsychotic drugs
6. Anesthesia drugs
7. Other opioids
8. Blood thinners
9. Antibiotics
10. Antifungal drugs
11. Heart rhythm medications
12. Protease inhibitors
13. Seizure medications

While tramadol is not a blood thinner itself, it may interact with blood-thinning medications. It’s generally safe to take tramadol with anti-inflammatory drugs, but always consult your doctor before combining medications.

Common Side Effects of Tramadol

Like all medications, tramadol can cause side effects. Most of these occur when first starting the medication and often subside over time.

What are the most common side effects of tramadol?

• Dizziness
• Nausea
• Headaches
• Drowsiness
• Vomiting
• Itchiness
• Weakness
• Heartburn
• Dry mouth
• Diarrhea
• High blood pressure (in rare cases)

Less Common but Serious Side Effects

In rare cases (less than 5% of users), more severe side effects may occur. These can include:

• Allergic reactions
• Weight loss
• Rapid heartbeat
• Low blood pressure
• Confusion
• Fainting
• Rashes
• Menopausal symptoms
• Difficulty breathing
• Serotonin syndrome
• Respiratory depression

Serotonin syndrome, a potentially life-threatening condition caused by excessive serotonin in the body, is a rare but serious risk associated with tramadol use. Symptoms can range from mild to severe and may include hallucinations, rapid heartbeat, fluctuating blood pressure, nausea, muscle rigidity, and in extreme cases, coma.

Duration of Tramadol’s Effects: Factors to Consider

The duration of tramadol’s effects can vary depending on several factors, including the form and strength of the medication.

What is the average half-life of tramadol?

The half-life of tramadol is approximately 8 hours, meaning it takes this long for the concentration of the drug in the body to be reduced by half.

Different Forms of Tramadol and Their Duration

• Injections: Effects begin within 30 minutes and last about 6 hours
• Slow-acting tablets and capsules: Effects start within 60 minutes and can last up to 24 hours

Several factors can influence how long tramadol’s effects last in an individual:

• Age
• Sex
• Liver function
• Overall health
• Dosage
• Time between doses

People with reduced kidney or liver function may experience prolonged effects due to slower elimination of the drug from their system.

Proper Usage of Tramadol: Guidelines and Precautions

Taking tramadol as prescribed is crucial for its effectiveness and to minimize risks. Your doctor will determine the appropriate dosage based on your pain level and individual conditions.

What are the risks of improper tramadol usage?

• Sudden discontinuation can lead to withdrawal symptoms, including increased blood pressure
• Irregular dosing may reduce the drug’s effectiveness
• Taking too much can result in a potentially dangerous overdose

Always follow your doctor’s instructions carefully when taking tramadol. If you have concerns about your dosage or experience any unusual side effects, consult your healthcare provider immediately.

Tramadol and Blood Pressure: A Closer Look at the Connection

While tramadol is not primarily known for its effects on blood pressure, the relationship between this medication and cardiovascular health deserves closer examination. Understanding this connection can help patients and healthcare providers make informed decisions about pain management strategies.

Direct Effects on Blood Pressure

How does tramadol directly affect blood pressure?

Research suggests that tramadol’s direct impact on blood pressure is generally minimal. However, in rare cases, it can cause either an increase or decrease in blood pressure. The mechanism behind these changes is not fully understood but may be related to the drug’s effects on the central nervous system and its interaction with various neurotransmitters.

Indirect Effects Through Drug Interactions

While tramadol itself may not significantly alter blood pressure in most users, its interactions with other medications can indirectly affect cardiovascular function. For example, when combined with certain antidepressants, particularly those that increase serotonin levels, tramadol can potentially lead to serotonin syndrome, which may cause rapid fluctuations in blood pressure.

What precautions should be taken regarding tramadol and other medications?

• Always inform your doctor about all medications you’re taking, including over-the-counter drugs and supplements
• Be especially cautious if you’re on blood pressure medications or have a history of cardiovascular issues
• Monitor your blood pressure regularly if you’re prescribed tramadol, especially in the initial stages of treatment

Managing Pain and Blood Pressure: Balancing Act with Tramadol

For individuals dealing with chronic pain and blood pressure concerns, finding the right balance in medication can be challenging. Tramadol offers an option for pain management that, when used correctly, may have minimal impact on blood pressure for most users.

Alternative Pain Management Strategies

What are some alternative pain management strategies for those concerned about blood pressure?

• Non-opioid pain relievers (e.g., acetaminophen, NSAIDs)
• Physical therapy
• Acupuncture
• Mindfulness and meditation techniques
• Cognitive-behavioral therapy for pain management
• Topical pain relievers

Combining these strategies with or as alternatives to tramadol may help manage pain while minimizing potential cardiovascular risks. Always consult with your healthcare provider to determine the most appropriate pain management plan for your individual needs.

Monitoring and Managing Side Effects of Tramadol

While tramadol can be an effective pain management tool, it’s crucial to monitor for and manage any side effects that may occur. This is particularly important for those with pre-existing cardiovascular conditions or concerns about blood pressure.

Recognizing Warning Signs

What are the warning signs that tramadol may be affecting your cardiovascular health?

• Unexplained dizziness or lightheadedness
• Rapid or irregular heartbeat
• Chest pain or discomfort
• Severe headaches
• Shortness of breath
• Swelling in the extremities

If you experience any of these symptoms while taking tramadol, it’s important to seek medical attention promptly. These could be signs of adverse cardiovascular effects or other serious complications.

Regular Health Check-ups

For individuals on long-term tramadol therapy, regular health check-ups are essential. These check-ups should include:

• Blood pressure monitoring
• Heart rate checks
• Blood tests to assess liver and kidney function
• Discussions about any new symptoms or side effects

Your healthcare provider may adjust your tramadol dosage or recommend alternative pain management strategies based on these assessments.

Tramadol in Special Populations: Considerations for Blood Pressure

Certain groups may be more susceptible to the cardiovascular effects of tramadol, requiring special consideration and monitoring.

Elderly Patients

Why do elderly patients require special attention when prescribed tramadol?

Older adults may be more sensitive to the effects of tramadol due to age-related changes in metabolism and organ function. They may also be more likely to have pre-existing cardiovascular conditions or be taking multiple medications that could interact with tramadol.

Patients with Hypertension

For individuals with existing hypertension, careful monitoring is crucial when starting tramadol therapy. Your doctor may need to adjust your blood pressure medications or tramadol dosage to maintain optimal blood pressure control.

Pregnant Women

Pregnant women should use tramadol with caution, as it can potentially affect fetal development and maternal blood pressure. The risks and benefits should be carefully weighed and discussed with a healthcare provider.

The Future of Pain Management: Tramadol and Beyond

As our understanding of pain management and drug interactions evolves, so too does the approach to using medications like tramadol. Researchers continue to investigate safer and more effective ways to manage pain while minimizing cardiovascular risks.

Emerging Research

What new developments are on the horizon for pain management and blood pressure control?

• Novel drug formulations with reduced side effect profiles
• Targeted drug delivery systems to minimize systemic effects
• Personalized medicine approaches based on genetic profiles
• Integration of non-pharmacological pain management techniques

These advancements may offer new options for individuals who struggle with the balance between pain relief and blood pressure management.

The Role of Patient Education

As the landscape of pain management evolves, patient education becomes increasingly important. Understanding the potential effects of medications like tramadol on blood pressure and overall health empowers patients to make informed decisions about their treatment plans and actively participate in their healthcare.

Key areas of patient education include:

• Proper medication usage and adherence
• Recognition of side effects and when to seek medical attention
• The importance of regular health check-ups and monitoring
• Lifestyle factors that can impact both pain management and blood pressure

By fostering open communication between patients and healthcare providers, we can work towards more effective and safer pain management strategies that take into account individual health concerns, including blood pressure management.

Can Tramadol Raise or Lower Your Blood Pressure?

Some drugs can make blood pressure rise. Others can interact with your blood pressure medicine, preventing the drug from working correctly. Various studies have tried to analyze if there’s a connection between tramadol and blood pressure. Mainly because tramadol has been linked to high blood pressure and low blood pressure, pointing to a correlation between both.

What’s Tramadol?

Tramadol is a prescription painkiller medication that’s considered a synthetic opioid. It acts very similarly to other opioids, blocking pain receptors in the central nervous system (CNS). Tramadol is mainly used to treat moderate to severe pain. It is often prescribed to treat pain after surgery or chronic pain caused by conditions such as cancer or neuropathy.

Tramadol is the drug’s generic name. It’s available under several brand names, including Ultram, Ultracet, Qdolo, and ConZip.

How Tramadol Affects Blood Pressure

Although rare, some adverse reactions of tramadol affect blood pressure. After taking the drug, between 1 and 5 percent of tramadol users developed high blood pressure (hypertension). Less than 1% of tramadol users developed low blood pressure (hypotension) in the same studies.

While tramadol doesn’t seem to interact with blood pressure medications, other interactions are possible. Taking other drugs can interfere with how the body processes tramadol, so people experience fluctuations in their blood pressure. For example, tramadol isn’t a blood thinner, but it might interact with blood thinners.

Many drugs interact with tramadol, including:

• Antidepressants
• Headache drugs
• Hypnotics
• Benzodiazepines
• Antipsychotic drugs
• Anesthesia drugs
• Opioid drugs
• Blood thinners
• Antibiotics
• Antifungal drugs
• Heart rhythm drugs
• Protease inhibitors
• Seizure medications

Some people wonder if you can take tramadol with anti-inflammatories and other over-the-counter medications. While it’s generally safe to take tramadol with anti-inflammatories, it’s always best to consult with your doctor before introducing new drugs.

Even though blood pressure changes are not a common side effect of tramadol, medication interactions can cause extreme changes in blood pressure. With so many drug interactions for tramadol, it is essential to discuss before taking the drug with your doctor.

Additionally, people taking tramadol should avoid taking additional opioid medications and consuming alcohol.

Tramadol Side Effects

Tramadol taken orally can cause drowsiness and sleepiness. Most tramadol side effects occur when people first start taking the drug and usually wear off over time. The most common side effects of tramadol include:

• Dizziness
• Nausea
• Headaches
• Drowsiness
• Vomiting
• Itchiness
• Weakness
• Heartburn
• Dry mouth
• Diarrhea
• High blood pressure

In sporadic cases (less than 5% of people taking tramadol), some less common and severe side effects may occur, including:

• Allergic reactions
• Weight loss
• Rapid heartbeat
• Lower blood pressure
• Confusion
• Fainting
• Rashes
• Menopausal symptoms
• Difficulty breathing
• Serotonin syndrome
• Respiratory depression

Serotonin symptoms occur when there’s too much serotonin in the body. It can cause anywhere from mild to fatal symptoms, if not appropriately addressed. In sporadic cases, people taking tramadol can experience serotonin syndrome and exhibit symptoms such as hallucinations, rapid heartbeat, fluctuating blood pressure, nausea, muscle rigidity, and coma.

How Long Do the Effects of Tramadol Last?

Tramadol is available in different forms and strengths that will change how long its effects last. On average, the half-life of tramadol is 8 hours. This means it takes eight hours after taking the drug for the concentration of tramadol in the body to be cut by half. The half-life of tramadol will significantly vary depending on its presentation, for example:

• Injections: start working within 30 minutes and last 6 hours.
• Slow-acting tablets and capsules: start working within 60 minutes and last for 24 hours.

Various factors such as age, sex, liver function, and overall health will affect how long the effects of tramadol last. People with reduced kidney or liver function may have more significant difficulties expelling the substance from their system. Dosage, time in-between doses, and other factors may also contribute to how long the effects last.

Taking Tramadol

How much tramadol you can take depends greatly on your level of pain and conditions. Your doctor will determine the proper dosage for your treatment plan. It comes with serious risks if you don’t take tramadol as prescribed.

• Stopping tramadol suddenly can make your pain continue and cause withdrawal symptoms, including increased blood pressure.
• Not taking the drug on schedule may cause tramadol to work less effectively or stop working altogether.
• Taking too much can cause a tramadol overdose, with symptoms such as muscle weakness, low blood pressure, and seizures.

When taking tramadol, follow the doctor’s prescription orders to prevent any side effects or withdrawal symptoms. In addition, let your doctor know about any changes in blood pressure while using this medication. Although rare, the correlation between tramadol and blood pressure exists. If you experience any changes, it’s worth it to consult with your doctor to seek tramadol alternatives to help with your pain.

Sources:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022370s000lbl.pdf
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cabccc8a-6f9f-414c-93f0-6dec331ed74b
https://www.ncbi.nlm.nih.gov/books/NBK537060/
https://www.ncbi.nlm.nih.gov/books/NBK482377/

Bleeding and Elevated INR Secondary to Concomitant Tramadol and Warfarin Administration

P T. 2019 Sep; 44(9): 546–548.

Author information Copyright and License information Disclaimer

Tramadol is a centrally active oral synthetic analgesic indicated for the management of moderate to severe pain. Tramadol and its major active metabolite (M1) bind to μ-opiate receptors in the central nervous system (CNS), causing the inhibition of ascending pain pathways; this alters the perception of and response to pain while weakly inhibiting the reuptake of norepinephrine and serotonin, neurotransmitters that are involved in the descending inhibitory pain pathway. ^1,2

Numerous drug interactions have been well documented with tramadol, but only sporadic case reports provide evidence of an interaction between the analgesic and warfarin in certain individuals that leads to an elevated international normalized ratio (INR), bruising, and/or hemorrhage.^3–10 If an interaction does occur, it will typically transpire within three to four days after the tramadol has been ingested by patients who are stabilized on warfarin. The normalization of INR can take up to several days after tramadol has been held. Clinicians should be cognizant of this interaction and closely monitor INR when it is necessary to prescribe a patient tramadol with warfarin, especially during the first week of treatment.¹¹

Case Report

This case illustrates the use of tramadol in a patient who was already on a stable regimen of warfarin. MR, an 86-year-old female, presented to the emergency department (ED) secondary to rectal bleeding for one day. In addition, she presented with a supratherapeutic INR of 5.4. Her pertinent medical history information included chronic atrial fibrillation, hypertension, diverticulosis, and asthma. The patient denied any nausea, vomiting, fever, chills, or vaginal/gum bleeding. Upon her admission, until the cause of hematochezia could be determined, MR was initiated on vitamin K; warfarin was held and INR laboratory values were monitored daily. A colonoscopy was performed, which showed non-bleeding internal hemorrhoids and diverticulosis in the sigmoid, descending colon, and proximal transverse colon. As no bleeding lesions were found during examination, the bleeding was thought to be secondary to diverticulosis versus hemorrhoids versus diffuse mucosal bleeding in the setting of supratherapeutic INR.

After a thorough medication reconciliation, only tramadol was found to interact with warfarin upon admission, and MR denied using any herbal or over-the-counter (OTC) agents as an outpatient. As a result, because of the potential interaction between tramadol and warfarin, gabapentin alone was continued for MR’s neuropathy. With the patient’s INR () and relevant blood values ( and ) trending toward a therapeutic range throughout her hospitalization, the medical team advised MR to continue gabapentin monotherapy for her chronic pain while they considered either dose titration or additional treatment modalities (if necessary). Warfarin was restarted for MR’s atrial fibrillation, and discharge planning was prepared on Day 4 of admission.

Table 1

Complete Blood Count

Test	Reference Range	Day 1	Day 2	Day 3	Day 4
Red Blood Cell Count	4. 00–5.20 MIL/uL	4.79	5.06	5.09	5.11
Hemoglobin	12.2–15.3 g/dL	12.6	12.9	13.2	13.4
Hematocrit	36–45%	40.4	41.7	42.9	43. 0
Mean Corpuscular Volume	80–96 fL	84.3	84.3	84.0	85.0
Mean Corpuscular Hgb	27–33 pg	26.1	26.1	26.2	26.3
Mean Corpuscular Hgb Concentration	33–36 g/dL	30. 7	30.9	31.0	31.2
Platelet Count	150–400 k/uL	176	181	201	206

Open in a separate window

Key: Hgb = hemoglobin

Table 2

Coagulation Tests

Test	Reference Range	Day 1	Day 2	Day 3	Day 4
Prothrombin Time (PT)	9. 5–12.0 seconds	55.8	28.9	14.0	12.6
Activated Partial Thromboplastin Time (aPTT)	26.1–33.8 seconds	34.0	30.0	NA	NA

Open in a separate window

The exact mechanism of a tramadol–warfarin interaction has not been fully determined; however, it is important to investigate as warfarin, a vitamin K antagonist, remains a widely used oral anticoagulant. Interactions with warfarin are generally attributed to metabolic inhibition, additive anticoagulation effects, or, less commonly, protein displacement. Tramadol is only 20% bound to plasma proteins and therefore is not considered to cause clinically significant displacement of warfarin.^3,5

It has been postulated that the effects of tramadol’s inhibition of serotonin reuptake might result in an increased bleeding tendency through a pharmacodynamic interaction similar to that of the selective serotonin reuptake inhibitor (SSRI) drug class. Serotonin is a relatively weak platelet activator, stored in platelets at rest; during platelet activation, it is released into circulation along with other factors and becomes a stimulus for platelet aggregation. A transporter protein is necessary to transport serotonin into the platelet, and, as SSRIs are antagonists of this transporter, this could account for the impairment of hemostasis. Tramadol’s similar inhibition of the reuptake of serotonin into platelets could result in decreased clot formation and a subsequent increase in the risk of bleeding. This is one possible mechanism that might have caused our patient’s hematochezia. ^{3,5, 12–15}

Warfarin is metabolized by cytochrome P450 isoenzymes (CYPs), with CYP2C9 being responsible for the majority of the metabolism of the S-enantiomer, which is more potent than the R-enantiomer, including CYP2C9, 2C19, 2C8, 2C18, 1A2, and 3A4. Tramadol also undergoes metabolism via several pathways, including CYP2D6 and CYP3A4. Some researchers propose that the competition for CYP3A4 metabolism increases levels of R-warfarin, prolongs the prothrombin (PT) time, and subsequently increases the INR.⁵

There is considerable variability in the pharmacokinetic and pharmacodynamic properties of tramadol depending on the patient’s genetic background. This has been partly attributed to CYP2D6 polymorphisms, as the enzyme plays a critical role in generating the M1 metabolite. The N-desmethylation to N-desmethyltramadol metabolite (M2) is catalyzed by CYP2B6 and CYP3A4 and is not pharmacologically active. ¹⁶

In 2004, a report from Sweden suggested that patients with mutations in the CYP2D6 gene or patients taking pharmacological inhibitors of this isoenzyme might also be at increased risk for this tramadol–warfarin interaction.^3,5,10 Subrahmanyam et al. concluded in their study that individuals who carry mutated CYP2D6 alleles form less of the CYP2D6-mediated metabolite M1 and more of the CYP3A4-mediated metabolite M2, postulating that “it would be reasonable that changes in the disposition of tramadol associated with reduced CYP2D6 activity could potentially increase the risk of an interaction with warfarin.”¹⁷ Pharmacogenomic CYP2D6 laboratory testing for tramadol, however, is not routinely performed and is only available in certain centers for individualized medicine. But because clinical reimbursement rates vary, medical providers should consider contacting the laboratory or the patient’s insurance provider for details before ordering such tests. ¹⁶

Concurrent administration of tramadol and warfarin warrants the close monitoring of INR levels, which can reach supratherapeutic ranges within days and predispose the patient to potentially fatal bleeding events. The current package insert for tramadol includes a statement that post-marketing surveillance data have revealed rare instances of increases in INR levels in patients who are also receiving warfarin. It has been recommended that when tramadol is prescribed on a long-term basis, the stable therapeutic warfarin dose should “initially be reduced by 25% with close monitoring of the INR. The INR should be rechecked no later than one week after the start of tramadol therapy.”³ The use of tramadol on an as-needed basis in patients taking warfarin is not recommended because of the drug’s potential to alter the INR response.³

Our patient’s Naranjo score, which assesses the probability of a drug causing an adverse event, was 8 (), indicating a probable adverse drug reaction. Thus, practitioners should be aware of the possibility of a tramadol–warfarin interaction, and consider other analgesics; at the least, caution should be employed when tramadol is prescribed for a patient, until the interaction has been investigated more thoroughly. Patients should be counseled to monitor and report signs of bleeding or bruising, and laboratory parameters should be monitored closely for elevations in PT and INR with tramadol and warfarin coadministration.¹⁸

Table 3

Naranjo’s Algorithm¹⁹

	Naranjo’s Algorithm: Determination of Adverse Drug-Reaction Probability	YES	NO	DO NOT KNOW	SCORE
1.	Are there previous conclusive reports on this reaction?	+1	0	0	+1
2.	Did the adverse event occur after the suspected drug was administered?	+2	−1	0	+2
3.	Did the adverse reaction improve when the drug was discontinued or when a specific antagonist was administered?	+2	0	0	+2
4.	Did the adverse reaction reappear when the drug was re-administered?	+2	−1	0	0
5.	Are there alternative causes (other than the drug) that could have caused the reaction on their own?	−1	+2	0	+2
6.	Did the reaction reappear when a placebo was given?	−1	+1	0	0
7.	Was the drug detected in the blood (or other fluids) in concentrations known to be toxic?	+1	0	0	0
8.	Was the reaction more severe when the dose was increased or less severe when the dose was decreased?	+1	0	0	0
9.	Did the patient have a similar reaction to the same or similar drugs in any previous exposure?	+1	0	0	0
10.	Was the adverse event confirmed by any objective evidence?	+1	0	0	+1
	TOTAL SCORE				8

Open in a separate window

Total score: ≥ 9 highly probable; 5–8 probable; 1–4 possible; ≤ 0 doubtful

In MR’s case, the exact interval between initiating tramadol therapy and the onset of its interaction with warfarin was not determined. Moreover, had the possibility of this interaction been recognized upon presentation, a colonoscopy might not have been warranted. Our patient was eventually counseled on alternative treatment modalities to alleviate her neuropathic pain. However, if a medical provider deems it necessary to continue a patient on current pain management with tramadol, reductions in weekly warfarin doses should be considered to prevent INR from reaching supratherapeutic levels.

Disclosure: The authors report no financial or commercial interest in regard to this article.

1. Ultram (tramadol) prescribing information. Gurabo, Puerto Rico: Janssen Ortho LLC; 2019. [Accessed August 7, 2019]. Available at: http://www.janssenlabels.com/package-insert/product-monograph/prescribinginformation/ULTRAM-pi.pdf. [Google Scholar]

2. Gibson TP. Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCL. Am J Med. 1996;101(1A):47S–53S. doi: 10.1016/s0002-9343(96)00138-6. [PubMed] [CrossRef] [Google Scholar]

3. Dumo PA, Kielbasa LA. Successful anticoagulation and continuation of tramadol therapy in the setting of a tramadol–warfarin interaction. Pharmacotherapy. 2006;26(11):1654–1657. doi: 10.1592/phco.26.11.1654. [PubMed] [CrossRef] [Google Scholar]

4. Scher ML, Huntington NH, Vitillo JA. Potential interaction between tramadol and warfarin. Ann Pharmacother. 1997;31(5):646–647. doi: 10.1177/106002809703100523. [PubMed] [CrossRef] [Google Scholar]

5. Sabbe JR, Sims PJ, Sims MH. Tramadol-warfarin interaction. Pharmacotherapy. 1998;18(4):871–873. [PubMed] [Google Scholar]

6. Dong SJ, Zhang T, Li Y, Zhai SD. Pharmaceutical care of serious bleeding induced by tramadol–warfarin interaction: a case report. Beijing Da Xue Xue Bao Yi Xue Ban. 2014;46(5):809–813. [Article in Chinese] [PubMed] [Google Scholar]

7. Madsen H, Rasmussen JM, Brøsen K. Interaction between tramadol and phenprocoumon. Lancet. 1997;350(9078):637. doi: 10.1016/S0140-6736(05)63325-9. [PubMed] [CrossRef] [Google Scholar]

8. Juel J, Pedersen TB, Langfrits CS, Jensen SE. Administration of tramadol or ibuprofen increases the INR level in patients on warfarin [published online June 17, 2012] Eur J Clin Pharmacol. 2013;69(2):291–292. doi: 10.1007/s00228-012-1325-3. [PubMed] [CrossRef] [Google Scholar]

9. Pottegård A, Meegaard PM, Holck LH, et al. Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation: a register-based nested case-control study [published online July 31, 2012] Eur J Clin Pharmacol. 2013;69(3):641–646. doi: 10.1007/s00228-012-1363-x. [PubMed] [CrossRef] [Google Scholar]

10. Hedenmalm K, Lindh JD, Säwe J, Rane A. Increased liability of tramadol–warfarin interaction in individuals with mutations in the cytochrome P450 2DG gene [published online June 10, 2004] Eur J Clin Pharmacol. 2004;60(5):369–372. doi: 10.1007/s00228-004-0783-7. [PubMed] [CrossRef] [Google Scholar]

11. Savage R. Evidence for tramadol–warfarin interaction. Prescriber Update. 2006;27(2):23–24. Available at: https://www.medsafe.govt.nz/profs/PUarticles/TramWarf.htm. Accessed August 7, 2019. [Google Scholar]

12. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics. 1996;37(1):12–16. doi: 10.1016/S0033-3182(96)71592-X. [PubMed] [CrossRef] [Google Scholar]

13. Paton C, Ferrier IN. SSRIs and gastrointestinal bleeding. BMJ. 2005;331(7516):529–530. doi: 10.1136/bmj.331.7516.529. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

14. Hougardy DM, Egberts TC, van der Graaf F, et al. Serotonin transporter polymorphism and bleeding time during SSRI therapy [published online February 12, 2008] Br J Clin Pharmacol. 2008;65(5):761–766. doi: 10.1111/j.1365-2125.2008.03098.x. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

15. de Abajo FJ. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes, and implications for use in elderly patients.